MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

20 May 2025 Evaluate
The sales slipped to Rs. 377.36 millions for the March 2025 quarter as against Rs. 420.11 millions during the year-ago period.The Net Profit of the company registered a slight decline of -24.48% to Rs. 119.97  millions from Rs. 158.86 millions.Operating profit for the quarter ended March 2025 decreased to 173.86 millions as compared to 219.49 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 377.36 420.11 -10.18 1508.00 1698.22 -11.20 1508.00 1698.22 -11.20
Other Income 13.48 10.18 32.42 24.32 43.66 -44.30 24.32 43.66 -44.30
PBIDT 173.86 219.49 -20.79 712.76 831.00 -14.23 712.76 831.00 -14.23
Interest 0.71 0.75 -5.33 3.64 2.29 58.95 3.64 2.29 58.95
PBDT 173.15 218.74 -20.84 709.12 828.71 -14.43 709.12 828.71 -14.43
Depreciation 12.28 9.25 32.76 53.75 35.36 52.01 53.75 35.36 52.01
PBT 160.87 209.49 -23.21 655.37 793.35 -17.39 655.37 793.35 -17.39
TAX 40.90 50.63 -19.22 167.66 201.71 -16.88 167.66 201.71 -16.88
Deferred Tax 2.32 0.97 139.18 2.80 3.75 -25.33 2.80 3.75 -25.33
PAT 119.97 158.86 -24.48 487.71 591.64 -17.57 487.71 591.64 -17.57
Equity 108.97 72.64 50.01 108.97 72.64 50.01 108.97 72.64 50.01
PBIDTM(%) 46.07 52.25 -11.82 47.27 48.93 -3.41 47.27 48.93 -3.41
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..